Research Publications Full text articles from PubMed Central, links to NLM PubMed abstracts and additional resources are available from this page.
Editorial: Intellectual Disabilities in Down Syndrome from Birth and Throughout Life: Assessment and Treatment, 2016
Pharmacological approaches to improving cognitive function in DS: Current status, 2014
Prospects for improving brain function in individuals with Down syndrome, 2013
Is it Possible to Improve Neurodevelopmental Abnormalities in Down Syndrome?, 2011
Emerging Pharmacotherapies for Neurodevelopmental Disorders, 2010
Antioxidants, Vitamins & Minerals
Oxidative stress and Down syndrome. Do antioxidants play a role in therapy? 2014
Antioxidants in Down syndrome, 2012.
Complementary and Alternative Therapies for DS, 2005.
Systematic Review of the Effects of Therapeutic Dietary Supplements and Drugs on Cognitive Function in Subjects with DS, 2002.
Acetylcholinesterase Inhibitors, Glutamatergics, GABAergics and more
Pharmacological interventions for cognitive decline in people with DS, 2015
GABAA receptor subtypes: Therapeutic
The glutamatergic hypothesis for Down syndrome: the potential use of N-methyl-D-aspartate receptor antagonists to enhance cognition and decelerate neurodegeneration, 2014
DS and AD: Common pathways common goals, 2015
Review of Donepezil, Rivastigmine, Galantamine and Mematine for the Treatment of Dementia in AD in Adults with DS, 2004